<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2026 Workiva-->
<!--r:019e651d-9b5f-7a55-9fed-78ac47ca9eec,g:b425a278-5b4d-4dc1-a188-5526d4c63dcf-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="https://xbrl.org/2023/arcrole/summation-item" xlink:type="simple" xlink:href="https://www.xbrl.org/2023/calculation-1.1.xsd#summation-item"/>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="vrdn-20260630.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e651d-9cb3-793a-a51d-6239c45434ad" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_019e651d-9cb3-7ca0-a8e6-34c1ede944e3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e651d-9cb3-793a-a51d-6239c45434ad" xlink:to="loc_us-gaap_CommonStockValue_019e651d-9cb3-7ca0-a8e6-34c1ede944e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_019e651d-9cb3-7ec3-9784-613c8676e75c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e651d-9cb3-793a-a51d-6239c45434ad" xlink:to="loc_us-gaap_AdditionalPaidInCapital_019e651d-9cb3-7ec3-9784-613c8676e75c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e651d-9cb3-72c8-bb4f-75ba20a0748f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e651d-9cb3-793a-a51d-6239c45434ad" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_019e651d-9cb3-72c8-bb4f-75ba20a0748f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_019e651d-9cb3-7b6f-81cd-37968a9e3e99" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e651d-9cb3-793a-a51d-6239c45434ad" xlink:to="loc_us-gaap_PreferredStockValue_019e651d-9cb3-7b6f-81cd-37968a9e3e99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019e651d-9cb3-74ca-b338-362d6aa88867" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_019e651d-9cb3-793a-a51d-6239c45434ad" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_019e651d-9cb3-74ca-b338-362d6aa88867" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019e651d-9cb3-7fbd-8818-303a02876344" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e651d-9cb3-7d53-add5-b6376e0db53d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e651d-9cb3-7fbd-8818-303a02876344" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_019e651d-9cb3-7d53-add5-b6376e0db53d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_019e651d-9cb3-7d48-9ceb-010888b5b535" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e651d-9cb3-7fbd-8818-303a02876344" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_019e651d-9cb3-7d48-9ceb-010888b5b535" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherReceivablesNetCurrent_019f233f-4052-70c4-b5eb-6152cd5dd8f8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherReceivablesNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e651d-9cb3-7fbd-8818-303a02876344" xlink:to="loc_us-gaap_OtherReceivablesNetCurrent_019f233f-4052-70c4-b5eb-6152cd5dd8f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019f233f-4052-775e-92ed-e676de54693f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_019e651d-9cb3-7fbd-8818-303a02876344" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_019f233f-4052-775e-92ed-e676de54693f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_019e651d-9cb3-77ed-92a0-6046127ca3c5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_019e651d-9cb3-7ba2-8180-3ca96c78f47d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e651d-9cb3-77ed-92a0-6046127ca3c5" xlink:to="loc_us-gaap_AssetsCurrent_019e651d-9cb3-7ba2-8180-3ca96c78f47d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_019e651d-9cb3-7c55-b2df-7ad9e2f87a91" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e651d-9cb3-77ed-92a0-6046127ca3c5" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_019e651d-9cb3-7c55-b2df-7ad9e2f87a91" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e651d-9cb3-7048-9183-9d8a0f35efdc" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e651d-9cb3-77ed-92a0-6046127ca3c5" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_019e651d-9cb3-7048-9183-9d8a0f35efdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e651d-9cb3-726b-be44-d8204ef161d7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e651d-9cb3-77ed-92a0-6046127ca3c5" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019e651d-9cb3-726b-be44-d8204ef161d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_019f5a9d-d8b4-7945-9468-e18bbde16c24" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_019e651d-9cb3-77ed-92a0-6046127ca3c5" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_019f5a9d-d8b4-7945-9468-e18bbde16c24" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e651d-9cb3-7609-b503-39718b437119" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_019e651d-9cb3-74de-80f0-14164bb70c2a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e651d-9cb3-7609-b503-39718b437119" xlink:to="loc_us-gaap_StockholdersEquity_019e651d-9cb3-74de-80f0-14164bb70c2a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_019e651d-9cb3-737e-93ed-70f0566f5709" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e651d-9cb3-7609-b503-39718b437119" xlink:to="loc_us-gaap_CommitmentsAndContingencies_019e651d-9cb3-737e-93ed-70f0566f5709" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019e651d-9cb3-7b0b-91d5-fbfbeb10e5eb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_019e651d-9cb3-7609-b503-39718b437119" xlink:to="loc_us-gaap_Liabilities_019e651d-9cb3-7b0b-91d5-fbfbeb10e5eb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019e651d-9cb3-74a8-a263-aff5d6826156" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_019e651d-9cb3-7d07-9e3a-6a9f045e6204" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e651d-9cb3-74a8-a263-aff5d6826156" xlink:to="loc_us-gaap_AccountsPayableCurrent_019e651d-9cb3-7d07-9e3a-6a9f045e6204" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019e651d-9cb3-74f0-8ba6-acf4bc47e24b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_019e651d-9cb3-74a8-a263-aff5d6826156" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_019e651d-9cb3-74f0-8ba6-acf4bc47e24b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_019e651d-9cb3-724c-9570-30d9d971167e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_019e651d-9cb3-728b-a5d9-e5ae9f79fc3f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e651d-9cb3-724c-9570-30d9d971167e" xlink:to="loc_us-gaap_LiabilitiesCurrent_019e651d-9cb3-728b-a5d9-e5ae9f79fc3f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SecuredLongTermDebt_019e651d-9cb3-7c9a-b31c-c59529fa9dde" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SecuredLongTermDebt"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e651d-9cb3-724c-9570-30d9d971167e" xlink:to="loc_us-gaap_SecuredLongTermDebt_019e651d-9cb3-7c9a-b31c-c59529fa9dde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_019e651d-9cb3-7b1c-ba0b-757df85b4ba6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e651d-9cb3-724c-9570-30d9d971167e" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_019e651d-9cb3-7b1c-ba0b-757df85b4ba6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLongTermDebtNoncurrent_019e651d-9cb3-7e62-abc7-57a446e6ab17" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherLongTermDebtNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e651d-9cb3-724c-9570-30d9d971167e" xlink:to="loc_us-gaap_OtherLongTermDebtNoncurrent_019e651d-9cb3-7e62-abc7-57a446e6ab17" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_019e651d-9cb3-7d7c-8a59-15e0003bff13" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e651d-9cb3-724c-9570-30d9d971167e" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_019e651d-9cb3-7d7c-8a59-15e0003bff13" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_019f234a-8635-77e8-8951-92c90fcef17b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_019e651d-9cb3-724c-9570-30d9d971167e" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_019f234a-8635-77e8-8951-92c90fcef17b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="simple" xlink:href="vrdn-20260630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONSANDCOMPREHENSIVELOSS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_019e651d-9cb3-7c9a-a320-edd9cfef21cf" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e651d-9cb3-7490-8349-1077f0d58f49" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019e651d-9cb3-7c9a-a320-edd9cfef21cf" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e651d-9cb3-7490-8349-1077f0d58f49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e651d-9cb3-7d2b-a12d-cc4fa2d47795" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_019e651d-9cb3-7c9a-a320-edd9cfef21cf" xlink:to="loc_us-gaap_NetIncomeLoss_019e651d-9cb3-7d2b-a12d-cc4fa2d47795" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e651d-9cb3-7f93-b9b3-a9006cc2dbcd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_019e651d-9cb3-7bf3-beee-db28aa7f20f3" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e651d-9cb3-7f93-b9b3-a9006cc2dbcd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_019e651d-9cb3-7bf3-beee-db28aa7f20f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_019e651d-9cb3-7262-b33b-3cc58c4f5fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_019e651d-9cb3-7f93-b9b3-a9006cc2dbcd" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_019e651d-9cb3-7262-b33b-3cc58c4f5fb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e651d-9cb3-7611-a4b2-9374d0cb1620" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019e651d-9cb3-7e3d-ac42-b21885fa072b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e651d-9cb3-7611-a4b2-9374d0cb1620" xlink:to="loc_us-gaap_OperatingExpenses_019e651d-9cb3-7e3d-ac42-b21885fa072b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019e651d-9cb3-7fc4-a99f-a811968d985c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_019e651d-9cb3-7611-a4b2-9374d0cb1620" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019e651d-9cb3-7fc4-a99f-a811968d985c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019e651d-9cb3-7c67-98b4-fc0621aebf2b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_019e651d-9cb3-7873-92b1-24e345f75e2b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e651d-9cb3-7c67-98b4-fc0621aebf2b" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_019e651d-9cb3-7873-92b1-24e345f75e2b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019e651d-9cb3-7606-8ac1-9732e7ee05e7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e651d-9cb3-7c67-98b4-fc0621aebf2b" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_019e651d-9cb3-7606-8ac1-9732e7ee05e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019e651d-9cb3-7904-8dfe-ac17e8341e2f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_019e651d-9cb3-702e-8f74-44ff0d8eb310" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019e651d-9cb3-7904-8dfe-ac17e8341e2f" xlink:to="loc_us-gaap_InvestmentIncomeInterest_019e651d-9cb3-702e-8f74-44ff0d8eb310" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_019e651d-9cb3-72a2-938c-5fd0376e333d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019e651d-9cb3-7904-8dfe-ac17e8341e2f" xlink:to="loc_us-gaap_InterestExpenseNonoperating_019e651d-9cb3-72a2-938c-5fd0376e333d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_019e651d-9cb3-7b59-9efd-9af847b4ef94" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019e651d-9cb3-7904-8dfe-ac17e8341e2f" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_019e651d-9cb3-7b59-9efd-9af847b4ef94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingIncomeExpenseNet_019e651d-9cb3-72c3-a641-9ea385e4464e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherOperatingIncomeExpenseNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NonoperatingIncomeExpense_019e651d-9cb3-7904-8dfe-ac17e8341e2f" xlink:to="loc_us-gaap_OtherOperatingIncomeExpenseNet_019e651d-9cb3-72c3-a641-9ea385e4464e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e651d-9cb3-79c2-93eb-d4db0dd99eac" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_019e651d-9cb3-727f-9fad-f0d045dc7813" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e651d-9cb3-79c2-93eb-d4db0dd99eac" xlink:to="loc_us-gaap_OperatingIncomeLoss_019e651d-9cb3-727f-9fad-f0d045dc7813" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_019e651d-9cb3-7c96-adc2-785e3eef2a43" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e651d-9cb3-79c2-93eb-d4db0dd99eac" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_019e651d-9cb3-7c96-adc2-785e3eef2a43" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="vrdn-20260630.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e651d-9cb4-77ab-978a-1854c467134d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e651d-9cb4-7ecd-8766-39ba388251da" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e651d-9cb4-77ab-978a-1854c467134d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e651d-9cb4-7ecd-8766-39ba388251da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e651d-9cb4-78c5-b3c0-a24d557a9fb2" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e651d-9cb4-77ab-978a-1854c467134d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e651d-9cb4-78c5-b3c0-a24d557a9fb2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e651d-9cb4-7055-9a5e-7e24f0c35aae" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_019e651d-9cb4-77ab-978a-1854c467134d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e651d-9cb4-7055-9a5e-7e24f0c35aae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e651d-9cb4-7d5d-b393-d88aac9ab127" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_019e651d-9cb4-748c-9461-64eaf28e67ed" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e651d-9cb4-7d5d-b393-d88aac9ab127" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_019e651d-9cb4-748c-9461-64eaf28e67ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_019e651d-9cb4-76fa-8f9d-de028b64b304" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e651d-9cb4-7d5d-b393-d88aac9ab127" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_019e651d-9cb4-76fa-8f9d-de028b64b304" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019e651d-9cb4-7b29-9ebb-06c8cb603937" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_019e651d-9cb4-7d5d-b393-d88aac9ab127" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_019e651d-9cb4-7b29-9ebb-06c8cb603937" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e651d-9cb4-7bff-aca5-409c034f0dd8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_019e651d-9cb4-73ca-9f8e-f19b5d56b599" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e651d-9cb4-7bff-aca5-409c034f0dd8" xlink:to="loc_us-gaap_AccretionAmortizationOfDiscountsAndPremiumsInvestments_019e651d-9cb4-73ca-9f8e-f19b5d56b599" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeGainLossOnDerivativeNet_019e651d-9cb4-7ed6-91f0-de3422fb1e27" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DerivativeGainLossOnDerivativeNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e651d-9cb4-7bff-aca5-409c034f0dd8" xlink:to="loc_us-gaap_DerivativeGainLossOnDerivativeNet_019e651d-9cb4-7ed6-91f0-de3422fb1e27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_019e651d-9cb4-7b67-b890-2b7decb0d0f0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_GainsLossesOnExtinguishmentOfDebt"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e651d-9cb4-7bff-aca5-409c034f0dd8" xlink:to="loc_us-gaap_GainsLossesOnExtinguishmentOfDebt_019e651d-9cb4-7b67-b890-2b7decb0d0f0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e651d-9cb4-7b8f-9fa7-d122635829b0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e651d-9cb4-7bff-aca5-409c034f0dd8" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_019e651d-9cb4-7b8f-9fa7-d122635829b0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e651d-9cb4-7021-aec2-b31c7eb3c3b7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e651d-9cb4-7bff-aca5-409c034f0dd8" xlink:to="loc_us-gaap_NetIncomeLoss_019e651d-9cb4-7021-aec2-b31c7eb3c3b7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_019e651d-9cb4-78dd-8b5d-aff05a5b6659" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e651d-9cb4-7bff-aca5-409c034f0dd8" xlink:to="loc_us-gaap_ShareBasedCompensation_019e651d-9cb4-78dd-8b5d-aff05a5b6659" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_019e651d-9cb4-79d0-aebc-dfd6f7c295c8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaidInKindInterest"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e651d-9cb4-7bff-aca5-409c034f0dd8" xlink:to="loc_us-gaap_PaidInKindInterest_019e651d-9cb4-79d0-aebc-dfd6f7c295c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_019e651d-9cb4-7af0-8bab-9d4e62b8d3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e651d-9cb4-7bff-aca5-409c034f0dd8" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_019e651d-9cb4-7af0-8bab-9d4e62b8d3b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrdn_NonCashLeaseExpense_019e651d-9cb4-7958-9d3a-346a3077f1c9" xlink:href="vrdn-20260630.xsd#vrdn_NonCashLeaseExpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e651d-9cb4-7bff-aca5-409c034f0dd8" xlink:to="loc_vrdn_NonCashLeaseExpense_019e651d-9cb4-7958-9d3a-346a3077f1c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019e651d-9cb4-736f-9cc8-db192cc78f9c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e651d-9cb4-7bff-aca5-409c034f0dd8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_019e651d-9cb4-736f-9cc8-db192cc78f9c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_019eba51-d3c2-70b3-9992-3166d548fa26" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e651d-9cb4-7bff-aca5-409c034f0dd8" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_019eba51-d3c2-70b3-9992-3166d548fa26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_019eba52-24b4-7121-b34b-2fc999e2a6a6" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_019e651d-9cb4-7bff-aca5-409c034f0dd8" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_019eba52-24b4-7121-b34b-2fc999e2a6a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e651d-9cb4-7840-8ba2-a5d5f94a6c01" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_019e651d-9cb4-7f7c-ad0f-19bc14eab58e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e651d-9cb4-7840-8ba2-a5d5f94a6c01" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_019e651d-9cb4-7f7c-ad0f-19bc14eab58e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_019e651d-9cb4-727d-b5a5-c91a2362bedb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromIssuanceOfPrivatePlacement"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e651d-9cb4-7840-8ba2-a5d5f94a6c01" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfPrivatePlacement_019e651d-9cb4-727d-b5a5-c91a2362bedb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019e651d-9cb4-7eeb-87c5-e0a15036c2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e651d-9cb4-7840-8ba2-a5d5f94a6c01" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_019e651d-9cb4-7eeb-87c5-e0a15036c2f8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_019e651d-9cb4-7b93-b0a8-608e302221cb" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e651d-9cb4-7840-8ba2-a5d5f94a6c01" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_019e651d-9cb4-7b93-b0a8-608e302221cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfDebtIssuanceCosts_019e651d-9cb4-705b-9304-df2bc873fe36" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_PaymentsOfDebtIssuanceCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e651d-9cb4-7840-8ba2-a5d5f94a6c01" xlink:to="loc_us-gaap_PaymentsOfDebtIssuanceCosts_019e651d-9cb4-705b-9304-df2bc873fe36" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfLongTermDebt_019f235a-1cbd-71fa-878c-4351cc8ad23f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RepaymentsOfLongTermDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e651d-9cb4-7840-8ba2-a5d5f94a6c01" xlink:to="loc_us-gaap_RepaymentsOfLongTermDebt_019f235a-1cbd-71fa-878c-4351cc8ad23f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_019f235a-1cbd-773f-a65c-b0e7906a72e7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e651d-9cb4-7840-8ba2-a5d5f94a6c01" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_019f235a-1cbd-773f-a65c-b0e7906a72e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_019f235a-1cbd-71b1-a834-aa9192cd75c1" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e651d-9cb4-7840-8ba2-a5d5f94a6c01" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_019f235a-1cbd-71b1-a834-aa9192cd75c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockPlans_019f82f4-a9f9-7ebd-8bc8-e5eecd81f793" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ProceedsFromStockPlans"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_019e651d-9cb4-7840-8ba2-a5d5f94a6c01" xlink:to="loc_us-gaap_ProceedsFromStockPlans_019f82f4-a9f9-7ebd-8bc8-e5eecd81f793" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSScheduleofDebtSecuritiesAvailableforsaleDetails" xlink:type="simple" xlink:href="vrdn-20260630.xsd#MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSScheduleofDebtSecuritiesAvailableforsaleDetails"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSScheduleofDebtSecuritiesAvailableforsaleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019e651d-9cb4-7e0d-bccc-be79830af3e8" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_019e651d-9cb4-7e35-bb2b-482c549882c0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019e651d-9cb4-7e0d-bccc-be79830af3e8" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_019e651d-9cb4-7e35-bb2b-482c549882c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_019e651d-9cb4-76d0-b5f9-6c9a708a624f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019e651d-9cb4-7e0d-bccc-be79830af3e8" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_019e651d-9cb4-76d0-b5f9-6c9a708a624f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019e651d-9cb4-7077-84b9-4c793f098469" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_019e651d-9cb4-7e0d-bccc-be79830af3e8" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019e651d-9cb4-7077-84b9-4c793f098469" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="simple" xlink:href="vrdn-20260630.xsd#MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/MARKETABLESECURITIESANDFAIRVALUEMEASUREMENTSScheduleofFairValueAssetsandLiabilitiesMeasuredonRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_019e651d-9cb4-794b-8319-73ae3b0d0762" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019e651d-9cb4-76f3-bffc-7b021cdb67a5" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_019e651d-9cb4-794b-8319-73ae3b0d0762" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_019e651d-9cb4-76f3-bffc-7b021cdb67a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019e651d-9cb4-7de7-90aa-f247e2cd48ef" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_019e651d-9cb4-794b-8319-73ae3b0d0762" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_019e651d-9cb4-7de7-90aa-f247e2cd48ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesFairValueDisclosure_019e651d-9cb4-76c3-a56e-06f22a99ad41" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LiabilitiesFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_019e651d-9cb4-7b95-ad69-84f82a319f7f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DerivativeLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesFairValueDisclosure_019e651d-9cb4-76c3-a56e-06f22a99ad41" xlink:to="loc_us-gaap_DerivativeLiabilities_019e651d-9cb4-7b95-ad69-84f82a319f7f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/INTANGIBLEASSETNETScheduleofEstimatedFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="vrdn-20260630.xsd#INTANGIBLEASSETNETScheduleofEstimatedFutureAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/INTANGIBLEASSETNETScheduleofEstimatedFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019f5ac2-b0a5-72a5-a155-5f7123753d42" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_019f5ac2-b0a5-75bb-b037-0e2e30f8f11f" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019f5ac2-b0a5-72a5-a155-5f7123753d42" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_019f5ac2-b0a5-75bb-b037-0e2e30f8f11f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_019f5ac2-b0a5-76af-8dfb-cde1b3da5fdd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019f5ac2-b0a5-72a5-a155-5f7123753d42" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_019f5ac2-b0a5-76af-8dfb-cde1b3da5fdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_019f5ac2-b0a5-7886-b23a-e34b5d0f0d5e" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019f5ac2-b0a5-72a5-a155-5f7123753d42" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_019f5ac2-b0a5-7886-b23a-e34b5d0f0d5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_019f5ac2-b0a5-7e8f-a3d3-f95483e19df7" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019f5ac2-b0a5-72a5-a155-5f7123753d42" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_019f5ac2-b0a5-7e8f-a3d3-f95483e19df7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_019f5ac2-b0a5-78bf-95ab-16c1355e656b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019f5ac2-b0a5-72a5-a155-5f7123753d42" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_019f5ac2-b0a5-78bf-95ab-16c1355e656b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrdn_IntangibleAssetFiniteLivedEstimatedAmortizationExpenseAfterYearFour_019f5ac2-b0a5-7892-ab1b-490efc9cdad7" xlink:href="vrdn-20260630.xsd#vrdn_IntangibleAssetFiniteLivedEstimatedAmortizationExpenseAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_019f5ac2-b0a5-72a5-a155-5f7123753d42" xlink:to="loc_vrdn_IntangibleAssetFiniteLivedEstimatedAmortizationExpenseAfterYearFour_019f5ac2-b0a5-7892-ab1b-490efc9cdad7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/ACCRUEDLIABILITIESDetails" xlink:type="simple" xlink:href="vrdn-20260630.xsd#ACCRUEDLIABILITIESDetails"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/ACCRUEDLIABILITIESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_019e651d-9cb4-7711-aada-1697ed088346" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrdn_AccruedOutsourcedManufacturingCurrent_019e651d-9cb4-7d21-8647-d1511a432fdd" xlink:href="vrdn-20260630.xsd#vrdn_AccruedOutsourcedManufacturingCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019e651d-9cb4-7711-aada-1697ed088346" xlink:to="loc_vrdn_AccruedOutsourcedManufacturingCurrent_019e651d-9cb4-7d21-8647-d1511a432fdd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrdn_AccruedOutsourcedClinicalAndNonclinicalStudiesCurrent_019e651d-9cb4-7dae-9a9e-2f575db1431f" xlink:href="vrdn-20260630.xsd#vrdn_AccruedOutsourcedClinicalAndNonclinicalStudiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019e651d-9cb4-7711-aada-1697ed088346" xlink:to="loc_vrdn_AccruedOutsourcedClinicalAndNonclinicalStudiesCurrent_019e651d-9cb4-7dae-9a9e-2f575db1431f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019e651d-9cb4-7d87-a5eb-1c5fa9cda5fd" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019e651d-9cb4-7711-aada-1697ed088346" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_019e651d-9cb4-7d87-a5eb-1c5fa9cda5fd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_019e651d-9cb4-774f-ab6c-2317f8ebd0ef" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019e651d-9cb4-7711-aada-1697ed088346" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_019e651d-9cb4-774f-ab6c-2317f8ebd0ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrdn_AccruedMilestonePaymentCurrent_019e651d-9cb4-737c-bcdb-bad9c57bc4ab" xlink:href="vrdn-20260630.xsd#vrdn_AccruedMilestonePaymentCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019e651d-9cb4-7711-aada-1697ed088346" xlink:to="loc_vrdn_AccruedMilestonePaymentCurrent_019e651d-9cb4-737c-bcdb-bad9c57bc4ab" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_019e651d-9cb4-71ef-abf9-59e4f0eda70d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019e651d-9cb4-7711-aada-1697ed088346" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_019e651d-9cb4-71ef-abf9-59e4f0eda70d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019e651d-9cb4-76b6-9943-39d494bf1a27" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019e651d-9cb4-7711-aada-1697ed088346" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_019e651d-9cb4-76b6-9943-39d494bf1a27" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPayableCurrent_019e651d-9cb4-78fa-a96a-145abfe20c54" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_InterestPayableCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019e651d-9cb4-7711-aada-1697ed088346" xlink:to="loc_us-gaap_InterestPayableCurrent_019e651d-9cb4-78fa-a96a-145abfe20c54" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019e651d-9cb4-77de-817b-7b66aed7f69b" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_019e651d-9cb4-7711-aada-1697ed088346" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_019e651d-9cb4-77de-817b-7b66aed7f69b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" xlink:type="simple" xlink:href="vrdn-20260630.xsd#DEBTScheduleofLongTermDebtInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/DEBTScheduleofLongTermDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_019e651d-9cb4-78f8-bf20-78568c91d407" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_019e651d-9cb4-755e-b770-2d2c997cdd0c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_019e651d-9cb4-78f8-bf20-78568c91d407" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_019e651d-9cb4-755e-b770-2d2c997cdd0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_019e651d-9cb4-77cb-9de6-6b6beed49800" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_019e651d-9cb4-78f8-bf20-78568c91d407" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_019e651d-9cb4-77cb-9de6-6b6beed49800" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.viridiantherapeutics.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="simple" xlink:href="vrdn-20260630.xsd#SEGMENTINFORMATIONScheduleofSegmentReportingInformationbySegmentDetails"/>
  <link:calculationLink xlink:role="http://www.viridiantherapeutics.com/role/SEGMENTINFORMATIONScheduleofSegmentReportingInformationbySegmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_019e651d-9d64-7a39-b08c-1a976a2e305a" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019e651d-9d64-729d-b5ca-1892970af75d" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e651d-9d64-7a39-b08c-1a976a2e305a" xlink:to="loc_us-gaap_OperatingExpenses_019e651d-9d64-729d-b5ca-1892970af75d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019e651d-9d64-776d-adf4-b107ef77e46c" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e651d-9d64-7a39-b08c-1a976a2e305a" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax_019e651d-9d64-776d-adf4-b107ef77e46c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_019e651d-9d64-732f-9876-11d99fb28ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_019e651d-9d64-7a39-b08c-1a976a2e305a" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_019e651d-9d64-732f-9876-11d99fb28ad0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_019e651d-9d64-78d0-a5f0-0a2b3fef2340" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_019e651d-9d64-7b02-9dff-b6838c362d40" xlink:href="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e651d-9d64-78d0-a5f0-0a2b3fef2340" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_019e651d-9d64-7b02-9dff-b6838c362d40" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrdn_ResearchAndDevelopmentExpenseExcludingShareBasedCompensationExpense_019e651d-9d64-7720-9ae5-8a0d85f0cfb0" xlink:href="vrdn-20260630.xsd#vrdn_ResearchAndDevelopmentExpenseExcludingShareBasedCompensationExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e651d-9d64-78d0-a5f0-0a2b3fef2340" xlink:to="loc_vrdn_ResearchAndDevelopmentExpenseExcludingShareBasedCompensationExpense_019e651d-9d64-7720-9ae5-8a0d85f0cfb0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_vrdn_SellingGeneralAndAdministrativeExpenseExcludingShareBasedCompensationExpense_019e651d-9d64-7dcd-a00f-9bbd32e17453" xlink:href="vrdn-20260630.xsd#vrdn_SellingGeneralAndAdministrativeExpenseExcludingShareBasedCompensationExpense"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="https://xbrl.org/2023/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_019e651d-9d64-78d0-a5f0-0a2b3fef2340" xlink:to="loc_vrdn_SellingGeneralAndAdministrativeExpenseExcludingShareBasedCompensationExpense_019e651d-9d64-7dcd-a00f-9bbd32e17453" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
